Covid-19 vaccine: Results of Covaxin trials on children to be out by September, says AIIMS chief

By: |
July 24, 2021 11:35 AM

Guleria said that the clinical trials of Covaxin vaccine are going on among children and the efficacy results are expected to be out by the month of September.

The vaccine maker is conducting clinical trials of the Covavax vaccine on the adult population and is expected to release its results soon.The vaccine maker is conducting clinical trials of the Covavax vaccine on the adult population and is expected to release its results soon. (Representative image)

Covid-19 vaccine update: In a crucial statement, AIIMS chief Dr. Randeep Guleria today said that the clinical trials of Bharat Biotech’s Covaxin vaccine are currently being undertaken on children and the results of the same are expected to be released by September. Guleria, who is one of the top health professionals advising the central government on its Covid-19 strategy, said that the clinical trials of Covaxin vaccine are going on among children and the efficacy results are expected to be out by the month of September, news agency ANI quoted.

The statement comes in the wake of a large number of health experts stating that children will be worst affected in the probable third wave of Coronavirus in the country as they remain most vulnerable due to the unavailability of vaccines for children. Experts have noted that the virus is most likely to attack the bodies of children as they remain the single largest non-immunised age group in the country against Coronavirus.

Dr. Guleria on asked about the vaccine availability for children said that Hyderabad-based vaccine manufacturer Bharat Biotech is conducting trials on children and the government will take a call on vaccinating children only after the efficacy of the vaccine among children is established. It is pertinent to note that Bharat Biotech is already supplying Covaxin vaccine doses for the adult vaccination programme currently underway in the country.

Pune-based Serum Institute of India, which is manufacturing AstraZeneca and Oxford University-developed Covishield in the country, has also requested the drug regulator to begin Covavax trials on children. Covavax is the second Coronavirus vaccine that the Pune-based Serum Institute is manufacturing in the country. The vaccine maker is conducting clinical trials of the Covavax vaccine on the adult population and is expected to release its results soon.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1US OKs new use for Eli Lilly’s COVID-19 treatment
2No Delta plus variant of COVID-19 found in 376 samples tested in Mumbai: BMC
3Coronavirus India News Latest Update Live: At 34,403, India logs over 30K new Covid-19 cases for second day in a row; Centre eyes record vaccination on PM’s birthday